跳至主要内容
临床试验/JPRN-UMIN000001656
JPRN-UMIN000001656已完成未知

Evaluation of efficacy and safety of active vitamin D treatment for secondary hyperparathyroidism in patients on maintenance hemodialysis; competitive study - Randomized clinical trial with alfacalcidol versus maxacalcitol

Division of Nephrology Department of Medicine Showa University School of Medicin0 个研究点目标入组 40 人开始时间: 2009年1月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Malignancy,malnutrition, active inflammatory or infectious disease 2)Severe heart failure and liver dysfunction 3)Pregnancy, during breast-feeding 4)Patients with allergy to affacalcidol and maxacalcitol 5)Primary hyperparathyroidism patients 6)Aluminum and Fe associated bone disease patients 7)Post parathyroidectomy patients, patients received percutaneous ethanol or vitamin D injection 8) Judged inappropriate for this study by the physicians 9)Parients who were recruited another clinical trial within 3 months

研究者

发起方
Division of Nephrology Department of Medicine Showa University School of Medicin

相似试验